May. 16 2024
Source Page: Managing radioactive substances and nuclear decommissioningFound: For example, the UK routinely and safely imports medical radioisotopes for use in hospitals.
Feb. 08 2023
Source Page: UK Radioactive Waste and Material Inventory 2022Found: Total radio activity is made up of the sum of the radio activities of radionuclides (or radioisotopes
Feb. 08 2023
Source Page: UK Radioactive Waste and Material Inventory 2022Found: Total radio activity is made up of the sum of the radio activities of radionuclides (or radioisotopes
Written Evidence Sep. 07 2022
Inquiry: Nuclear power in WalesFound: global geopolitics the possibility of Trawsfynydd hosting a nuclear facility capable of producing radioisotopes
Feb. 08 2023
Source Page: UK Radioactive Waste and Material Inventory 2022Found: Unstable nuclides are known as radionuclides (also called radioisotopes), and the transformation process
Feb. 08 2023
Source Page: UK Radioactive Waste and Material Inventory 2022Found: Unstable nuclides are known as radionuclides (also called radioisotopes), and the transformation process
Asked by: Mohammad Yasin (Labour - Bedford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the availability of shielded rooms in the NHS in the context of the potential increase in availability of (a) radioligand therapy and (b) other nuclear medicines to treat certain cancers.
Answered by James Morris
No specific assessment has been made. Further work is required on the safe delivery of the service with an appropriate number of providers to balance patient access with available specialist expertise and infrastructure.
Asked by: Henry Smith (Conservative - Crawley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of the availability of shielded rooms in the context of the likely increase in the availability of (a) radioligand therapy and (b) other nuclear medicines to treat certain cancers.
Answered by James Morris
No specific assessment has been made. Further work is required on the safe delivery of the service with an appropriate number of providers to balance patient access with available specialist expertise and infrastructure.
Jun. 07 2023
Source Page: Integrated information requirements, costing processes and costing methods 2023Found: administered via a drink, capsules, a cannula or as an injection: the radiation treatments are also known as radioisotopes
Asked by: Daisy Cooper (Liberal Democrat - St Albans)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the sustainability of the nuclear medicine workforce in the context of the potential increase in availability of (a) radioligand therapy and (b) other nuclear medicines to treat certain cancers.
Answered by James Morris
No specific assessment has been made. However, Health Education England plan to increase the number of posts in nuclear medicine by 10 each year in 2023/24 and 2024/25 through its cancer and diagnostic programme.
It is expected that all new therapeutic radioligand treatments for cancer will be appraised by the National Institute of Health and Care Excellence via its technology appraisal process.